Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.

Background: PCA3 has been included in a nomogram outperforming previous clinical models for the prediction of any prostate cancer (PCa) and high grade PCa (HGPCa) at the initial prostate biopsy (IBx). Our objective is to validate such IBx-specific PCA3-based nomogram. We also aim to optimize the use...

Descripción completa

Detalles Bibliográficos

Publicado en:	BMC Cancer Vol. 15; no. 1; pp. 1 - 9
Autores principales:	Rubio-Briones, Jose, Borque, Angel, Esteban, Luis M., Casanova, Juan, Fernandez-Serra, Antonio, Rubio, Luis, Casanova-Salas, Irene, Sanz, Gerardo, Domínguez-Escrig, Jose, Collado, Argimiro, Gómez-Ferrer, Alvaro, Iborra, Inmaculada, Ramírez-Backhaus, Miguel, Martínez, Francisco, Calatrava, Ana, Lopez-Guerrero, Jose A.
Formato:	research tables/charts Journal Article
Publicado:	BioMed Central 9/12/2015
Acceso en línea:	Ver este registro en EBSCOhost